ExploreWatchlistsPricing
  1. JP-listed companies
  2. TSUMURA & CO.
  3. Financials
  4. Operating margin (%)

TSUMURA & CO. (4540)

Market cap
¥290.1B
P/E ratio
11.8x
Tsumura manufactures prescription and over-the-counter medicines, specializing in herbal extract powders and raw medicinal herbs across Japan, China, Laos, and the US.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndOperating margin (%) YoY (%)
Mar 31, 202522.2+66.97%
Mar 31, 202413.3-11.15%
Mar 31, 202314.9-13.53%
Mar 31, 202217.3+16.64%
Mar 31, 202114.8-3.31%
Mar 31, 202015.3-0.01%
Mar 31, 201915.3+5.90%
Mar 31, 201814.5+4.03%
Mar 31, 201713.9-21.02%
Mar 31, 201617.6-0.26%
Mar 31, 201517.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat